Pharming Group N.V. PHARM.AS Stock
Pharming Group N.V. Price Chart
Pharming Group N.V. PHARM.AS Financial and Trading Overview
Pharming Group N.V. stock price | 1.01 EUR |
Previous Close | 1.12 EUR |
Open | 1.13 EUR |
Bid | 0 EUR x 0 |
Ask | 0 EUR x 0 |
Day's Range | 1.11 - 1.13 EUR |
52 Week Range | 0.66 - 1.42 EUR |
Volume | 1.98M EUR |
Avg. Volume | 11.16M EUR |
Market Cap | 731.17M EUR |
Beta (5Y Monthly) | 0.878544 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.01 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 6.98 EUR |
PHARM.AS Valuation Measures
Enterprise Value | 712.32M EUR |
Trailing P/E | N/A |
Forward P/E | 22.279999 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 3.6278155 |
Price/Book (mrq) | 3.5935483 |
Enterprise Value/Revenue | 3.534 |
Enterprise Value/EBITDA | -763.469 |
Trading Information
Pharming Group N.V. Stock Price History
Beta (5Y Monthly) | 0.878544 |
52-Week Change | 61.73% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1.42 EUR |
52 Week Low | 0.66 EUR |
50-Day Moving Average | 1.09 EUR |
200-Day Moving Average | 1.12 EUR |
PHARM.AS Share Statistics
Avg. Volume (3 month) | 11.16M EUR |
Avg. Daily Volume (10-Days) | 5.64M EUR |
Shares Outstanding | 656.35M |
Float | 599.72M |
Short Ratio | N/A |
% Held by Insiders | 2.29% |
% Held by Institutions | 17.74% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -0.99% |
Operating Margin (ttm) | -3.036% |
Gross Margin | 91.68% |
EBITDA Margin | -0.46% |
Management Effectiveness
Return on Assets (ttm) | -0.93% |
Return on Equity (ttm) | -1.014% |
Income Statement
Revenue (ttm) | 201.55M EUR |
Revenue Per Share (ttm) | 0.32 EUR |
Quarterly Revenue Growth (yoy) | -8.69% |
Gross Profit (ttm) | 188.06M EUR |
EBITDA | -933000 EUR |
Net Income Avi to Common (ttm) | -1995000 EUR |
Diluted EPS (ttm) | 0 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 184.78M EUR |
Total Cash Per Share (mrq) | 0.29 EUR |
Total Debt (mrq) | 170.4M EUR |
Total Debt/Equity (mrq) | 85.48 EUR |
Current Ratio (mrq) | 4.509 |
Book Value Per Share (mrq) | 0.31 |
Cash Flow Statement
Operating Cash Flow (ttm) | -936000 EUR |
Levered Free Cash Flow (ttm) | -1643375 EUR |
Profile of Pharming Group N.V.
Country | Netherlands |
State | N/A |
City | Leiden |
Address | Darwinweg 24 |
ZIP | 2333 CR |
Phone | 31 71 524 7400 |
Website | https://www.pharming.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 332 |
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks. It also engages in the development of leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome; OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE; and alpha-glucosidase therapy for the treatment of Pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. is headquartered in Leiden, the Netherlands.
Q&A For Pharming Group N.V. Stock
What is a current PHARM.AS stock price?
Pharming Group N.V. PHARM.AS stock price today per share is 1.01 EUR.
How to purchase Pharming Group N.V. stock?
You can buy PHARM.AS shares on the Amsterdam exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pharming Group N.V.?
The stock symbol or ticker of Pharming Group N.V. is PHARM.AS.
Which industry does the Pharming Group N.V. company belong to?
The Pharming Group N.V. industry is Biotechnology.
How many shares does Pharming Group N.V. have in circulation?
The max supply of Pharming Group N.V. shares is 673.44M.
What is Pharming Group N.V. Price to Earnings Ratio (PE Ratio)?
Pharming Group N.V. PE Ratio is now.
What was Pharming Group N.V. earnings per share over the trailing 12 months (TTM)?
Pharming Group N.V. EPS is -0.01 EUR over the trailing 12 months.
Which sector does the Pharming Group N.V. company belong to?
The Pharming Group N.V. sector is Healthcare.
Pharming Group N.V. PHARM.AS included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
AMX-Index AMX | 935.33 EUR 1022.44 USD |
-0.38
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}